Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | COVID-19 and cancer outcomes in the UK

David Pinato • 16 Apr 2021

David Pinato, MD, MRes, PhD, Imperial College London, London, UK, discusses his presentation on the OnCovid study which is investigating the outcomes of patients with cancer during the COVID-19 pandemic. Data from over 3,000 patients has been analyzed in the study. The study has reported an increased mortality rate in cancer patients in the UK, associated with age and fraility. Dr Pinato recommends that cancer patients receive the COVID-19 vaccine, commenting on the potential impacts of certain hematological malignancies on vaccine efficiency. This interview took place during the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.